Literature DB >> 28377425

High density lipoproteins selectively promote the survival of human regulatory T cells.

Cesar M Rueda1, Ana Lucia Rodríguez-Perea2, Maria Moreno-Fernandez1, Courtney M Jackson1, John T Melchior3, W Sean Davidson3, Claire A Chougnet4.   

Abstract

HDLs appear to affect regulatory T cell (Treg) homeostasis, as suggested by the increased Treg counts in HDL-treated mice and by the positive correlation between Treg frequency and HDL-cholesterol levels in statin-treated healthy adults. However, the underlying mechanisms remain unclear. Herein, we show that HDLs, not LDLs, significantly decreased the apoptosis of human Tregs in vitro, whereas they did not alter naïve or memory CD4+ T cell survival. Similarly, oleic acid bound to serum albumin increased Treg survival. Tregs bound and internalized high amounts of HDL compared with other subsets, which might arise from the higher expression of the scavenger receptor class B type I by Tregs; accordingly, blocking this receptor hindered HDL-mediated Treg survival. Mechanistically, we showed that HDL increased Treg ATP concentration and mitochondrial activity, enhancing basal respiration, maximal respiration, and spare respiratory capacity. Blockade of FA oxidation by etoxomir abolished the HDL-mediated enhanced survival and mitochondrial activity. Our findings thus suggest that Tregs can specifically internalize HDLs from their microenvironment and use them as an energy source. Furthermore, a novel implication of our data is that enhanced Treg survival may contribute to HDLs' anti-inflammatory properties.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  immunology; lipids/oxidation; lymphocytes; mitochondria

Mesh:

Substances:

Year:  2017        PMID: 28377425      PMCID: PMC5538275          DOI: 10.1194/jlr.M072835

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  63 in total

1.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.

Authors:  Valerie A Gerriets; Rigel J Kishton; Amanda G Nichols; Andrew N Macintyre; Makoto Inoue; Olga Ilkayeva; Peter S Winter; Xiaojing Liu; Bhavana Priyadharshini; Marta E Slawinska; Lea Haeberli; Catherine Huck; Laurence A Turka; Kris C Wood; Laura P Hale; Paul A Smith; Martin A Schneider; Nancie J MacIver; Jason W Locasale; Christopher B Newgard; Mari L Shinohara; Jeffrey C Rathmell
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

2.  [Impact of rhG-CSF on Sphingosine 1-phosphate receptor 1 expression in CD4+ T cells of donor peripheral blood].

Authors:  Hai-Yan Zhu; Wan-Ming DA; Chun-Ji Gao; Meng Li; Wei-Hua Chen; Li Yü; Wen-Rong Huang
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2010-04

Review 3.  Challenges in cryopreservation of regulatory T cells (Tregs) for clinical therapeutic applications.

Authors:  Karolina Golab; Dennis Leveson-Gower; Xiao-Jun Wang; Jakub Grzanka; Natalia Marek-Trzonkowska; Adam Krzystyniak; J Michael Millis; Piotr Trzonkowski; Piotr Witkowski
Journal:  Int Immunopharmacol       Date:  2013-02-18       Impact factor: 4.932

4.  Lipid free apolipoprotein E binds to the class B Type I scavenger receptor I (SR-BI) and enhances cholesteryl ester uptake from lipoproteins.

Authors:  Stéphanie Bultel-Brienne; Sophie Lestavel; Antoine Pilon; Isabelle Laffont; Anne Tailleux; Jean-Charles Fruchart; Gérard Siest; Véronique Clavey
Journal:  J Biol Chem       Date:  2002-07-22       Impact factor: 5.157

5.  SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells.

Authors:  N R Webb; P M Connell; G A Graf; E J Smart; W J de Villiers; F C de Beer; D R van der Westhuyzen
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

6.  De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.

Authors:  Luciana Berod; Christin Friedrich; Amrita Nandan; Jenny Freitag; Stefanie Hagemann; Kirsten Harmrolfs; Aline Sandouk; Christina Hesse; Carla N Castro; Heike Bähre; Sarah K Tschirner; Nataliya Gorinski; Melanie Gohmert; Christian T Mayer; Jochen Huehn; Evgeni Ponimaskin; Wolf-Rainer Abraham; Rolf Müller; Matthias Lochner; Tim Sparwasser
Journal:  Nat Med       Date:  2014-10-05       Impact factor: 53.440

7.  Mitochondrial and cytosolic roles of PINK1 shape induced regulatory T-cell development and function.

Authors:  Gavin I Ellis; Lianteng Zhi; Ravi Akundi; Hansruedi Büeler; Francesc Marti
Journal:  Eur J Immunol       Date:  2013-09-14       Impact factor: 5.532

Review 8.  Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium.

Authors:  Giuseppe D Norata; Alberico L Catapano
Journal:  Vasc Health Risk Manag       Date:  2005

9.  Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease.

Authors:  Katharina Lahl; Christoph Loddenkemper; Cathy Drouin; Jennifer Freyer; Jon Arnason; Gérard Eberl; Alf Hamann; Hermann Wagner; Jochen Huehn; Tim Sparwasser
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

10.  Moesin controls clathrin-mediated S1PR1 internalization in T cells.

Authors:  Akira Nomachi; Masanori Yoshinaga; Jaron Liu; Pakorn Kanchanawong; Kiyoshi Tohyama; Dean Thumkeo; Takeshi Watanabe; Shuh Narumiya; Takako Hirata
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

View more
  16 in total

1.  Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation.

Authors:  Megan R Showalter; Benjamin Wancewicz; Oliver Fiehn; Joehleen A Archard; Shannon Clayton; Joseph Wagner; Peter Deng; Julian Halmai; Kyle D Fink; Gerhard Bauer; Brian Fury; Nicholas H Perotti; Michelle Apperson; Janelle Butters; Peter Belafsky; Gregory Farwell; Maggie Kuhn; Jan A Nolta; Johnathon D Anderson
Journal:  Biochem Biophys Res Commun       Date:  2019-03-26       Impact factor: 3.575

Review 2.  Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

Authors:  Rai Ajit K Srivastava
Journal:  Mol Cell Biochem       Date:  2017-08-21       Impact factor: 3.396

Review 3.  The role of lipid metabolism in shaping the expansion and the function of regulatory T cells.

Authors:  Alessandra Pinzon Grimaldos; Simone Bini; Ilenia Pacella; Alessandra Rossi; Alessia Di Costanzo; Ilenia Minicocci; Laura D'Erasmo; Marcello Arca; Silvia Piconese
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

4.  Oleic acid restores suppressive defects in tissue-resident FOXP3 Tregs from patients with multiple sclerosis.

Authors:  Saige L Pompura; Allon Wagner; Alexandra Kitz; Jacob LaPerche; Nir Yosef; Margarita Dominguez-Villar; David A Hafler
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 5.  Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.

Authors:  Victoria A Blaho
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 6.  Metabolic Strategies for Inhibiting Cancer Development.

Authors:  Philippe Icard; Mauro Loi; Zherui Wu; Antonin Ginguay; Hubert Lincet; Edouard Robin; Antoine Coquerel; Diana Berzan; Ludovic Fournel; Marco Alifano
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

Review 7.  HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases.

Authors:  Fabrizia Bonacina; Angela Pirillo; Alberico L Catapano; Giuseppe D Norata
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

Review 8.  The role of high-density lipoprotein in the regulation of the immune response: implications for atherosclerosis and autoimmunity.

Authors:  Marisa Fernandes das Neves; Joana R Batuca; José Delgado Alves
Journal:  Immunology       Date:  2021-05-22       Impact factor: 7.215

Review 9.  The Redox-Metabolic Couple of T Lymphocytes: Potential Consequences for Hypertension.

Authors:  Cassandra M Moshfegh; Adam J Case
Journal:  Antioxid Redox Signal       Date:  2020-04-30       Impact factor: 8.401

Review 10.  HDL and persistent inflammation immunosuppression and catabolism syndrome.

Authors:  Grant Barker; Julia R Winer; Faheem W Guirgis; Srinivasa Reddy
Journal:  Curr Opin Lipidol       Date:  2021-10-01       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.